CTN & ATTC Webinar: Digital Therapeutics in the Treatment of SUD (Feb 15, 11am PT
February 15, 2023 | 11am-12:30pm PT | Register here!
Digital therapeutics–software used to prevent, treat, or manage a medical disorder or disease–are redefining the future of healthcare. Digital therapeutics package an entire model of care that can be delivered with fidelity and in accordance with state-of-the-science best practices into a unified, seamless digital delivery system. Digital therapeutics have been particularly transformative in the field of substance use, mental health, and other behavioral health conditions and can markedly improve access to care, quality of care, and treatment outcomes, while reducing costs, for a wide array of audiences in diverse settings.
In this presentation, Dr. Lisa A. Marsch (Dartmouth Center for Technology and Behavioral Health) will review the state of the science of digital therapeutics for behavioral health and timely opportunities to scale up access to these digital health tools via multiple paths to deployment around the world.
Learning objectives
- Recall the key findings from at least two (2) clinical trials focused on the use of digital therapeutics in substance use disorder treatment.
- Specify at least two (2) ways that digital data capture can be used to assess health behavior and provide personalized digital therapeutics.
- Assess the confluence of at least two (2) factors that increase the demand of and opportunities for scaling up access to behavioral health digital therapeutics.
1.5 CME or CE credits available. See flyer for details on accreditation.
Sponsored by the Northwest and Pacific Southwest ATTCs and the Western States Node of the NIDA CTN.